The Latest Breaking News from Moody

The RBI recently issued regulatory measures to banks and NBFCs to increase risk weights associated with consumer credit and bank credit by an additional 25 percentage points. We examine the rationale behind the move and its potential impact.

Plus: Hospital raid, Eric Adams' fondness for Erdogan, open carry at the makeup counter, and more...

Moody's calculates that interest payments on the national debt will consume over a quarter of federal tax revenue by 2033, up from just 9 percent last year.

December S&P 500 futures (ESZ23) are down -0.22%, and December Nasdaq 100 E-Mini futures (NQZ23) are down -0.29% this morning as risk sentiment took a hit after rating agency Moody’s lowered the United States’ credit rating outlook while investors looked ahead to the release of U.S. inflation data as well…

Sharemarket rally stalls as Mainfreight result highlights tighter conditions

House Speaker Mike Johnson unveiled his proposal on Saturday to avoid a partial government shutdown by extending government funding for some agencies and programs until Jan. 19 and continuing funding for others until Feb. 2.

The credit rating agency Moody’s Investors Service has lowered its outlook on the U_S_ government’s debt to “negative” from “stable.”

Company cites ‘continued political polarization’ and risks to the nation’s fiscal strength as reason for change

Less spending seen on A-list actors, special effects and on-location production

Asian shares are mostly lower in muted trading as attention focuses on prospects for improved China-U.S. relations from meetings next week on the sidelines of a Pacific Rim summit

The pharmaceutical sector is booming with increasing global healthcare demands and technological progress. Hence, top-rated pharma stocks Dr. Reddy’s (RDY), Novo Nordisk (NVO), and AbbVie (ABBV) might be solid additions to one’s portfolio in November. Read more.